Skip to main content
. 2018 Aug 1;67(10):1603–1609. doi: 10.1007/s00262-018-2217-x

Fig. 2.

Fig. 2

Vaccination protocol. SVN-2B vaccine and IFA were subcutaneously injected once every 2 weeks. Human IFN-α was simultaneously injected near IFA injection site on days 1, 4, 8, and 11. All three agents were repeatedly administered